EP Patent

EP2422787A1 — Diazoxide for use in the treatment of amyotrophic lateral sclerosis (als)

Assigned to Neurotec Pharma SL · Expires 2012-02-29 · 14y expired

What this patent protects

The invention relates to the diazoxide or a pharmaceutically acceptable salt thereof for use as a medicament at low doses to treat amyotrophic lateral sclerosis.

USPTO Abstract

The invention relates to the diazoxide or a pharmaceutically acceptable salt thereof for use as a medicament at low doses to treat amyotrophic lateral sclerosis.

Drugs covered by this patent

Patent Metadata

Patent number
EP2422787A1
Jurisdiction
EP
Classification
—
Expires
2012-02-29
Drug substance claim
No
Drug product claim
No
Assignee
Neurotec Pharma SL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.